| Schedule of Earnings Per Share, Basic and Diluted |
|
|
|
|
|
|
|
|
|
|
|
For the
three months
ended
September 30,
2022 |
|
|
For the
three months
ended
September 30,
2021 |
|
| |
|
$ |
1,343,981 |
|
|
$ |
(665,953 |
) |
Accretion of temporary equity to redemption value |
|
|
(796,360 |
) |
|
|
— |
|
| |
|
|
|
|
|
|
|
|
Net income (loss) including accretion of temporary equity to redemption value |
|
$ |
547,621 |
|
|
$ |
(665,953 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the
nine months
ended
September 30,
2022 |
|
|
For the period from March 9 , 2021 (inception) to September 30, 2021 |
|
| |
|
$ |
9,790,293 |
|
|
$ |
(666,572 |
) |
Accretion of temporary equity to redemption value |
|
|
(860,040 |
) |
|
|
— |
|
| |
|
|
|
|
|
|
|
|
Net income (loss) including accretion of temporary equity to redemption value |
|
$ |
8,930,253 |
|
|
$ |
(666,572 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended
September 30, |
|
|
For the period from March 9, 2021
(inception) through September 30, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted net income
(loss) per share of common
stock: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of net income (loss) including accretion of temporary equity |
|
$ |
438,097 |
|
|
$ |
109,524 |
|
|
$ |
(21,312,744 |
) |
|
$ |
(5,328,186 |
) |
|
$ |
7,144,202 |
|
|
$ |
1,786,051 |
|
|
$ |
(21,313,239 |
) |
|
$ |
(5,328,310 |
) |
Deemed dividend for accretion of temporary equity to redemption value |
|
|
796,360 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
860,040 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of net income (loss) |
|
$ |
1,234,457 |
|
|
$ |
109,524 |
|
|
$ |
(21,312,744 |
) |
|
$ |
(5,328,186 |
) |
|
$ |
8,004,242 |
|
|
$ |
1,786,051 |
|
|
$ |
(21,313,239 |
) |
|
$ |
(5,328,310 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares outstanding |
|
|
23,000,000 |
|
|
|
5,750,000 |
|
|
|
23,000,000 |
|
|
|
5,750,000 |
|
|
|
23,000,000 |
|
|
|
5,750,000 |
|
|
|
23,000,000 |
|
|
|
5,750,000 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted net income (loss) per common stock |
|
$ |
0.05 |
|
|
$ |
0.02 |
|
|
$ |
(0.93 |
) |
|
$ |
(0.93 |
) |
|
$ |
0.35 |
|
|
$ |
0.31 |
|
|
$ |
(0.93 |
) |
|
$ |
(0.93 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|